Jake Soucheray's questions to Delcath Systems Inc (DCTH) leadership • Q2 2025
Question
Jake Soucheray, on behalf of Chase Knickerbocker at Craig-Hallum, asked if joining the NDRA program has created more urgency for centers to become active. He also requested guidance on the expected ramp-up in R&D spending for new clinical trials.
Answer
CEO Gerard Michel stated the NDRA program has not created a noticeable increase in urgency, as site activation is complex with many gating items, but it does ease financial conversations. CFO Sandra Pennell projected R&D expenses would increase by another 40% in Q3 and 25-30% in Q4 over Q3, for a full-year increase of about 140% over 2024.